SCN5A and breast cancer: Correlatively, the inhibition of NaV1.5 activity was also responsible for a reduced activity of the downstream protagonist NHE-1, thus decreasing H+ efflux, preventing extracellular matrix degradation proteolytic activity, and inhibiting breast cancer cell invasiveness (Wannous et al., 2015).